Xiangyu Medical Co.,Ltd (SHA:688626)
57.84
+0.47 (0.82%)
Apr 29, 2026, 3:00 PM CST
Xiangyu Medical Co.,Ltd Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 9,027 | 9,442 | 4,574 | 8,375 | 5,028 | 9,107 | Upgrade
|
| Market Cap Growth | 53.95% | 106.45% | -45.39% | 66.55% | -44.79% | - | Upgrade
|
| Enterprise Value | 8,881 | 9,261 | 4,193 | 7,553 | 3,711 | 7,670 | Upgrade
|
| Last Close Price | 57.84 | 60.50 | 29.21 | 52.10 | 30.99 | 54.71 | Upgrade
|
| PE Ratio | 111.02 | 120.81 | 44.43 | 36.87 | 40.08 | 45.11 | Upgrade
|
| Forward PE | 83.83 | 73.66 | 15.53 | 27.97 | 24.02 | 33.29 | Upgrade
|
| PS Ratio | 11.65 | 12.30 | 6.15 | 11.24 | 10.29 | 17.40 | Upgrade
|
| PB Ratio | 4.27 | 4.54 | 2.23 | 3.97 | 2.59 | 4.68 | Upgrade
|
| P/TBV Ratio | 4.77 | 5.09 | 2.51 | 4.45 | 2.92 | 5.28 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 284.86 | Upgrade
|
| P/OCF Ratio | 46.81 | 49.74 | 25.61 | 36.75 | 26.93 | 54.90 | Upgrade
|
| EV/Sales Ratio | 11.46 | 12.06 | 5.64 | 10.14 | 7.60 | 14.65 | Upgrade
|
| EV/EBITDA Ratio | 67.17 | 78.18 | 39.87 | 36.22 | 53.22 | 49.96 | Upgrade
|
| EV/EBIT Ratio | 136.23 | 140.59 | 60.69 | 39.51 | 69.14 | 53.96 | Upgrade
|
| EV/FCF Ratio | -192.46 | - | - | - | - | 239.90 | Upgrade
|
| Debt / Equity Ratio | 0.32 | 0.28 | 0.18 | 0.02 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 5.11 | 4.46 | 3.42 | 0.17 | 0.25 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.10 | -0.18 | -0.37 | -0.69 | -0.76 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.28 | -1.69 | -3.58 | -3.79 | -19.30 | -9.63 | Upgrade
|
| Net Debt / FCF Ratio | 3.39 | 2.06 | 1.45 | 3.15 | 82.20 | -46.22 | Upgrade
|
| Asset Turnover | 0.24 | 0.25 | 0.27 | 0.30 | 0.22 | 0.33 | Upgrade
|
| Inventory Turnover | 0.87 | 0.95 | 1.05 | 1.05 | 0.89 | 1.17 | Upgrade
|
| Quick Ratio | 0.98 | 0.89 | 1.12 | 2.40 | 3.99 | 8.41 | Upgrade
|
| Current Ratio | 1.68 | 1.56 | 1.55 | 3.21 | 4.74 | 9.46 | Upgrade
|
| Return on Equity (ROE) | 3.77% | 3.67% | 4.94% | 11.28% | 6.35% | 14.84% | Upgrade
|
| Return on Assets (ROA) | 1.26% | 1.33% | 1.57% | 4.82% | 1.47% | 5.62% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.40% | 3.70% | 4.43% | 18.72% | 9.22% | 32.91% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.70% | 2.80% | 3.20% | 8.60% | 2.70% | 7.10% | Upgrade
|
| Earnings Yield | 0.89% | 0.83% | 2.25% | 2.71% | 2.50% | 2.22% | Upgrade
|
| FCF Yield | -0.51% | -1.03% | -5.69% | -3.00% | -0.33% | 0.35% | Upgrade
|
| Dividend Yield | 0.42% | - | 0.82% | 1.02% | 0.77% | 0.69% | Upgrade
|
| Payout Ratio | 48.88% | 56.85% | 83.14% | 17.81% | 47.77% | 29.43% | Upgrade
|
| Buyback Yield / Dilution | 0.38% | 1.75% | 1.12% | 0.68% | -6.20% | -24.97% | Upgrade
|
| Total Shareholder Return | 0.79% | 1.75% | 1.94% | 1.70% | -5.42% | -24.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.